| Ytd | 20.93% | |
| 1y | -27.44% |
| Open | 0.33 | Prev Close | 0.33 | Low | 0.32 | High | 0.36 | Mkt Cap | 29.58M |
| Vol | 43.58K | Avg Vol | 124.55K | EPS | -0.04 | P/E | N/A | Forward P/E | -21.75 |
| Beta | 1.08 | Short Ratio | 1.65 | Inst. Own | 5.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.43 | 200-d Avg | 0.35 | 1yr Est | 2.13 |
TerrAscend (OTCMKTS:TSNDF - Get Free Report) and Milestone Scientific (NYSE: MLSS - Get Free Report)
Gainers Flyte Aviation, Inc. Common Stock (AMEX:VJET) stock moved upwards by 34.0% to $2.17 during
Gainers NewGenIvf Group (NASDAQ:NIVF) stock moved upwards by 56.7% to $0.16 during Friday's pre
Synaptics surged 14.5% after amending its $123/share cash buyout by onsemi; AMOD led gainers, while
CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinic
Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's
ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS),
Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that
Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's aft
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to
Milestone Scientific (AMEX:MLSS) released second-quarter financial results and hosted an earnings ca
Medical Segment Revenue Grows 231% Year-Over-Year Enters Strategic Distribution Agreement to Expand
Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.01) per share which met the analys
ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading
Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare S
AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Suppo
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments
Medical Segment Momentum Accelerates, Posting 300% Growth Versus Q2 2025 Company to Showcase Technol
ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments
ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript
Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to
Operating Loss Reduced As Company Advances Toward Profitability Reaffirms Outlook for Double-Digit R
Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.01) per share which met the analys
ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading d
ROSELAND, N. J. , May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading
Financing Strengthens Balance Sheet and Supports Commercial Growth Strategy; Backed by Long-Term Inv
NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-ye
Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript
Milestone Scientific (AMEX:MLSS) sees FY2026 sales of $9.800 million-$10.200 million vs $9.910 milli
Q4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth,
Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.02) per share which missed the ana
ROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments